The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
420
Eight group Mindfulness Oriented Recovery Enhancement sessions and one motivational interviewing session and nicotine replacement therapy.
Eight group Mindfulness Oriented Recovery Enhancement sessions and nicotine replacement therapy.
Eight group support group sessions and one motivational interviewing session and nicotine replacement therapy.
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States
RECRUITINGUniversity of Utah
Salt Lake City, Utah, United States
RECRUITINGDays of Drug Use
Number of days of drug use as measured by self-reported days of use and biochemically verified use via drug screen.
Time frame: Baseline through 52 weeks.
Days of Tobacco Use
Number of days of tobacco use as measured by self-reported days of use and biochemically verified use via expired carbon monoxide.
Time frame: Baseline through 52 weeks.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Eight group support group sessions and and nicotine replacement therapy.